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        Classically, naive CD4  +   T cells have been thought 
to diff  erentiate into two main lineages, Th1 
and Th2 cells (  1, 2  ). Th1 cells produce the sig-
nature cytokine IFN-    , with the cytokine IL-
12 produced by DCs being critical for their 
diff  erentiation by inducing the activation of 
STAT-4 and up-regulation of T-bet transcrip-
tion factor. In contrast, Th2 cells produce IL-4, 
IL-5, IL-9, and IL-13, and their development 
is usually started by IL-4 signaling with the par-
ticipation of the transcription factors STAT-6 
and GATA-3 (  3  ). More recently, a third subset 
of CD4  +   eff  ector T cells that produce IL-17, 
named Th17, has been described in mice (  4, 5  ). 
These cells express a transcription factor diff  er-
ent from those of Th1 and Th2 cells, the reti-
noic acid  –  related orphan receptor     t (ROR    t) 
(  6  ). Human Th17 cells were found to be diff  erent 
from mouse Th17 cells not only with regard to 
some phenotypic and functional features, but 
mainly because of their diff  erent mechanisms 
of development (  7, 8  ). Several papers agree that 
mouse Th17 cells originate from naive CD4  +   
T cells in the presence of IL-6 and TGF-    , and 
their development is then stabilized and/or am-
plifi  ed by IL-23 and IL-21 (  9  –  11  ). In contrast, 
human Th17 cells seem to originate in response 
to the combined activity of IL-1     and IL-6 
(  12  ), or the activity of IL-1     or IL-23 alone 
(  13  ), whereas the combined activity of IL-1     
and IL-23 was not shown to have any additive 
or synergistic eff  ect (  13  ). Moreover, the addi-
tion of TGF-     to human naive or memory 
CD4  +   T cells was found to inhibit the develop-
ment of Th17 cells (  12  –  14  ). In another study, 
it was reported that IL-1     and IL-6 up-regu-
lated ROR    t expression but did not induce 
Th17 diff  erentiation in human adult naive CD4  +   
T cells, whereas IL-23 was a powerful up-regu-
lator of its own receptor and was an important 
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  We demonstrate that   CD161   is a highly up-regulated gene in human interleukin (IL) 17 T 
helper cell (Th17) clones and that all IL-17  –  producing cells are contained in the CD161  +   
fraction of CD4  +   T cells present in the circulation or in infl  amed tissues, although they are 
not CD1-restricted natural killer T cells. More importantly, we show that all IL-17  –  produc-
ing cells originate from CD161  +   naive CD4  +   T cells of umbilical cord blood, as well as of the 
postnatal thymus, in response to the combined activity of IL-1     and IL-23. These fi  ndings 
implicate CD161 as a novel surface marker for human Th17 cells and demonstrate the 
exclusive origin of these cells from a CD161  +  CD4  +   T cell progenitor. 
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shown in Tables S1  –  S4 (available at http://www.jem.org/
cgi/content/full/jem.20080397/DC1). Therefore, CD161 
expression was analyzed by either quantitative PCR or fl  ow 
cytometry on a series of human Th1, Th2, or Th17 clones 
derived from healthy subjects and diff  erent from those used 
for the microarray assay. As shown in   Fig. 1 B  , Th17 clones 
expressed higher levels of CD161 mRNA than Th1 and Th2 
clones, and virtually all of their T blasts expressed CD161, 
whereas T blasts from all Th1 and Th2 clones examined did 
not (  Fig. 1 C  ). CD161 expression by resting Th17 clones was 
not aff  ected by anti-CD3 plus anti-CD28 mAb stimulation 
in the presence of IL-2, and it was not induced on Th1 and 
Th2 clones (Fig. S1). 
  All circulating Th17 cells from adult healthy subjects 
and Th17 cells from infl  amed tissues are contained 
in the CD161  +   fraction 
  We then asked whether the CD161 expression observed in 
Th17 clones was also shared by freshly derived circulating 
Th17 cells. To this end, CD4  +   T cells purifi  ed from adult 
PBMCs of healthy subjects were sorted into CD161  +   and 
CD161        cells, and the sorted populations were assessed by 
fl  ow cytometry for their phenotypic features, as well as for 
their ability to produce IFN-     or IL-17 in response to PMA 
plus ionomycin stimulation. Virtually all CD161  +   cells were 
contained within the CD45RA       CD45RO  +  CD31        popula-
tion (Fig. S2, available at http://www.jem.org/cgi/content/
full/jem.20080397/DC1), suggesting their nature as memory 
T cells. Moreover, the cells of the CD161  +   fraction produced 
IFN-    , IL-17, or both, whereas IL-17  –  producing cells were 
virtually absent in the CD161        fraction (  Fig. 2 A  ).   Using the 
same technique, the assessment of the production of IL-21 
and IL-22 showed that both CD161        and CD161  +   cells were 
able to produce IL-21, whereas the ability to produce IL-22 
was virtually restricted to CD161  +   cells (Fig. S3). The CD161  +   
and CD161        fractions were also tested for ROR    t, IL-23R, 
and CCR6 mRNA expression. CD161  +   T cells expressed 
higher levels of mRNA for ROR    t, IL-23R, and CCR6 
than CD161        cells (  Fig. 2 A  ). Because human Th17 cells 
have been shown to express CCR6 (  7, 8  ), the association be-
tween CCR6 and CD161 was assessed. As shown in   Fig. 2 B  , 
the majority of CD161  +   T cells also expressed CCR6, and 
when CD161  +   cells were sorted into CCR6        and CCR6  +   
cells, the great majority of IL-17  –  producing cells appeared to 
be included in the CCR6  +   fraction. In contrast, the CD161        
fraction also contained CCR6  +   cells, but they were not ca-
pable of producing IL-17, whereas they produced IFN-     
(  Fig. 2 B  ). Accordingly, ROR    t and IL-23R mRNA ex-
pression appeared to be restricted to the CD161  +  CCR6  +   cell 
fraction (  Fig. 2 B  ). 
  To provide evidence of the presence of CD161  +   T cells, 
even in the infl  amed tissues where Th17 cells are suspected to 
play a pathogenic role (  18, 19  ), analysis by confocal microscopy 
on biopsy specimens of skin from psoriatic patients was also 
performed. As shown in  Fig. 3 A , high percentages of T (CD3  +  ) 
cells infi  ltrating the skin of psoriatic patients also coexpressed 
inducer of IL-17 and IL-22 (  15  ). The discrepancy among re-
sults between humans and mice, and among diff  erent human 
studies, with regard to the development of Th17 cells has 
been attributed to the diffi   culty to ensure a truly naive cell 
population in humans (  16  ). More recently, the combined ac-
tivity of IL-1     or IL-1     and IL-23 was found to be required 
for the enhancement of IL-17  –  producing human memory T 
cells; however, in the same study, the diff  erentiation of hu-
man naive T cells into Th17 cells could not be achieved (  17  ). 
In a previous paper, we showed that in addition to human 
memory T cells producing IL-17 alone (Th17), there are sev-
eral T cells in both blood and tissues that coproduce IL-17 
and IFN-     (Th17/Th1) (  8  ). We also found that these two 
cell types express both ROR    t and T-bet and that Th17 cells 
could be shifted to Th1 by the addition of IL-12, an eff  ect 
that was partially antagonized by IL-23, suggesting a fl  exibil-
ity of human Th17 cells and their possible common develop-
mental origin with Th1 cells (  8  ). Furthermore, we and others 
identifi  ed IL-23R and CCR6 as surface molecules expressed 
by human Th17 cells (  7, 8  ). 
  In this study, by using a microarray assay we found that 
  CD161   was one of the most up-regulated genes in human 
Th17 clones compared with Th1 or Th2 clones. Accordingly, 
T blasts from all Th17 clones expressed CD161 on their sur-
face, whereas all Th1 or Th2 clones examined were CD161       . 
All IL-17  –  producing cells were found to be included within 
the CD161  +   fraction of adult circulating CD4  +   T cells; they 
were not CD1d-restricted natural killer T (NKT) cells, but 
NKT-like cells. When CD161  +   or CD161        cells were sorted 
from umbilical cord blood (UCB)  –  naive CD4  +   T cells or from 
single-positive CD4  +  CD8        thymocytes and activated in the 
presence of IL-1     plus IL-23, Th17, Th17/Th1, or Th1, cells 
developed from the CD161  +   fraction, whereas CD161        cells 
could never been induced to diff  erentiate into IL-17  –  produc-
ing cells. In contrast, in the presence of IL-12, both CD161  +   
and CD161        cells only diff  erentiated into Th1 cells. These 
fi  ndings indicate that CD161 is a novel surface marker for hu-
man IL-17  –  producing cells and demonstrate that human Th17 
and Th17/Th1 cells exclusively originate from an NKT-like 
CD161  +  CD4  +   T cell precursor present in the UCB, in the 
presence of IL-1     and IL-23 as polarizing cytokines. 
    RESULTS   
  Human Th17, but neither Th1 nor Th2, clones express 
CD161 on their surface 
  In a previous study, we generated a series of Th1, Th2, and 
Th17 clones from human circulating CD4  +   T cells (  8  ). We 
performed a microarray analysis to identify possible diff  er-
ences in gene expression by Th17 clones compared with Th1 
or Th2 clones. Among genes that fulfi  lled the criteria de-
scribed in Materials and methods as up- or down-regulated 
genes in Th17 versus Th1 or Th2 clones, in addition to those 
expected on the basis of previous knowledge, such as   IL-17  , 
  IL-26  ,   IL-23R  ,   ROR    t  , and   CCR6   (  7, 8, 13  ), there was also 
  CD161   (  Fig. 1 A  ).   All genes showing a log  2   fold increase 
or decrease of   ≥  2.5 in Th17 versus Th1 and Th2 clones are JEM VOL. 205, August 4, 2008 
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repertoire, as shown by spectratyping analysis of both freshly 
isolated and 1-wk in vitro  –  expanded cells (  Fig. 4 A  ).   In addi-
tion, the presence of a broad TCR V     repertoire also ex-
cluded the possibility that these cells belong to the type II 
(nonclassical) NKT cells. Moreover, the response of purifi  ed 
CD161  +  CD4  +   circulating T cells to allogeneic stimulation, as 
assessed by CD154 expression, was comparable to that of the 
CD4  +  CD161        cell fraction, and, more importantly it could 
be inhibited by the addition in culture of a blocking anti  –
  MHC class II mAb (  Fig. 4 B  ). Furthermore, the expression of 
IFN-     and IL-17 in a purifi  ed protein derivative (PPD)  –  specifi  c 
short-term CD4  +   T cell line stimulated with PPD-loaded 
autologous DCs was equally inhibited by an anti  –  MHC class II 
mAb, as assessed by fl  ow cytometry (  Fig. 4 C  ). 
  IL-17  –  producing cells develop from UCB-naive T cells only 
in the presence of IL-1     plus IL-23 
  To identify conditions permissive for the diff  erentiation of 
human naive T cells into IL-17  –  producing cells, we fi  rst stim-
ulated purifi  ed CD45RA  +  RO        cells obtained from CD4  +   T 
cells of adult subjects for 7 d with anti-CD3 and anti-CD28 
mAbs, in the absence or presence of single cytokines (IL-1    , 
IL-6, IL-21, IL-23, and TGF-    ) or of combinations of them. 
CD161  +  , whereas virtually no T cells were observed in control 
skin specimens of healthy subjects.   To further support the re-
sults of the confocal microscopy analysis, infi  ltrating cells were 
recovered from both the infl  amed gut of subjects with Crohn  ’  s 
disease (CD) and the skin of subjects suff  ering from psoriasis, 
and expanded in vitro for 7 d with anti-CD3 plus anti-CD28 
mAb. Cultured cells were then stimulated with PMA plus ion-
omycin and examined for the expression of CD161 and for 
their ability to produce IFN-     or IL-17. Virtually all Th17 and 
Th17/Th1 cells were present in the CD3  +  CD8       CD161  +  -
gated T cells of both the gut from subjects with CD and the 
skin from subjects with psoriasis (  Fig. 3 B  ). 
  Circulating CD161  +   Th17 cells are not NKT cells, 
but NKT-like cells 
  Because CD161 has been reported to be expressed by diff  er-
ent cell types, including type I or II NKT cells or NKT-like 
cells (either CD4  +   or CD8  +   T cells; reference   20  ), we asked 
whether CD161  +   Th17 cells belonged to the NKT or the 
NKT-like T cell population. Circulating CD161  +  CD4  +   T 
cells containing IL-17  –  producing cells were not type I (or 
classical) invariant NKT (iNKT) cells because they had a 
polyclonal V    24 TCR chain and exhibited a broad TCR V     
    Figure 1.         Human Th17 clones express the NKT cell marker CD161.   (A) Volcano plot representation (log  2   fold change vs.   t   test p-value) between Th17 and 
Th1 (left) or Th2 (right) cell gene expression profi  les. (B) CD161 mRNA levels were measured by real-time quantitative RT-PCR in Th1, Th2, and Th17 clones. Bars 
represent mean values   ±   SE obtained in 10 clones from each type different from those used for the microarray assay. (C) Representative fl  ow cytometric analysis 
of CD161 surface expression for each type of clone. The gates were placed on the basis of an isotype-matched control mAb. Percentages of gated cells are shown.     1906 CD161 AND HUMAN T  H  17 CELLS   | Cosmi et al. 
    Figure 2.         Circulating IL-17  –  producing cells are contained in the CD161  +  CCR6  +   fraction of circulating CD4  +   T cells from adult subjects.  
(A) Detection of IL-17 and IFN-     production and expression of ROR    t, IL-23R, and CCR6 mRNA in CD161-depleted (black plot and bars) and CD161-enriched 
(red plot and bars) circulating CD4  +   T cells from healthy adult subjects. Representative fl  ow cytometric analysis (top) and mean values of cytokine-producing 
cell percentages   ±   SE obtained in seven different donors (bottom) are shown. (B) IL-17 and IFN-     production in circulating CD161      CCR6     ,  CD161     CCR6 + , 
CD161  + CCR6      , and CD161  + CCR6 +   CD4 +   T cells from one representative experiment out of three performed is shown. ROR    t and IL-23R mRNA expression in 
the indicated cell populations is shown. Bars represent mean values   ±   SE obtained in three separate experiments. Percentages of gated cells are shown.     JEM VOL. 205, August 4, 2008 
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of mRNA for ROR    t, T-bet, and IL-23R, but not of CD161 
or IL-17 (  Fig. 5 A  ).   When IL-1     and IL-23 were added to-
gether, there was a further up-regulation of T-bet, ROR    t, 
and IL-23R, as well as of CD161, mRNA expression in com-
parison with cultures containing IL-1     or IL-23 alone; in 
  addition, IL-17 mRNA expression became clearly detectable 
(  Fig. 5 A  ). In contrast, none of the other cytokines added 
to the cultures, alone or in diff  erent combinations, was able to 
increase ROR   t, IL-23R, IL-17, or CD161 mRNA expression 
We used fl  ow cytometry to analyze the production of IL-17 
after stimulation with PMA plus ionomycin. Under any of the 
experimental conditions used, cells producing IL-17 could 
never be observed (unpublished data). 
  UCB CD4  +   T cells were then used as source of naive T cells. 
These cells were cultured under the same conditions described 
in the previous paragraph, and their capacity to express mRNA 
for ROR    t, T-bet, IL-23R, CD161, and IL-17 was assessed. 
Either IL-1     or IL-23 signifi  cantly up-regulated the expression 
    Figure 3.         Detection of CD161  +   T cells in infl  amed tissues and demonstration of their ability to produce IL-17.   (A) Evaluation of the expression of 
CD3 (red) and CD161 (green) in skin from a healthy donor (top left) or in lesional skin from a psoriatic patient (top right) by confocal microscopy. Arrows point 
to cells showing double labeling for CD3 and CD161 (yellow) in the skin of the psoriatic patient. TO-PRO-3 (Invitrogen) counterstained nuclei. (bottom) A close-
up of CD3  + CD161 +   double-positive cells (merged; yellow) is shown. Images obtained in the skin of one out of three healthy or psoriatic donors are depicted. 
Bars, 10   μ  m. (B) Infi  ltrating T cells recovered from gut areas of subjects with CD or skin biopsies of subjects with psoriasis were expanded in vitro for 1 wk and 
assessed for CD161 expression, as well as for their ability to produce IFN-     and IL-17 after stimulation with PMA plus ionomycin. Representative fl  ow cyto-
metric analysis obtained in one out of three subjects with CD and in one out of three subjects with psoriasis are shown. Percentages of gated cells are shown.    1908 CD161 AND HUMAN T  H  17 CELLS   | Cosmi et al. 
metric analysis of UCB mononuclear cells (MNCs) showed 
the presence of a small but clearly detectable (0.76   ±   0.1% 
SE;   n   = 18) CD161  +   cell population among CD4  +   T cells.   
Therefore, UCB CD4  +   T cells were sorted into CD161        and 
CD161  +   cells. The purity of sorted populations was consis-
tently   >  95%, as shown in Fig. S5 (available at http://www
.jem.org/cgi/content/full/jem.20080397/DC1). The two 
sorted cell populations were then assessed for the expression 
of ROR    t, IL-23R, CCR6, and IL-17 mRNA. As shown 
in   Fig. 6 A  , only CD161  +   cells showed high levels of mRNA 
for ROR    t, IL-23R, and CCR6, suggesting the constitutive 
expression of these molecules in the CD161  +  , but not in the 
CD161       , fraction. However, neither CD161  +   nor CD161        
cells expressed the IL-17 transcript (  Fig. 6 A  ). Therefore, 
sorted CD161  +   and CD161        UCB CD4  +   T cells were stim-
ulated for 7 d with anti-CD3 plus anti-CD28 mAb in pres-
ence of IL-1     plus IL-23, or of IL-12 alone, and the expression 
of ROR    t and T-bet, as well as the type of cytokine produced, 
(Fig. S4, available at http://www.jem.org/cgi/content/full/
jem.20080397/DC1). Intracellular expression of IFN-     and 
IL-17 was also evaluated on the same CD4  +   T cell cultures 
by fl  ow cytometry after stimulation with PMA plus iono-
mycin. Virtually no cells producing IL-17 and only a few 
IFN-      –  producing cells were observed in the absence of 
  cytokines. The addition of either IL-1     or IL-23, or both, 
induced a signifi  cant increase in the proportion of CD4  +   T 
cells able to produce IFN-     (  Fig. 5, B and C  ), but only the 
combination of both IL-1     and IL-23 enabled UCB CD4  +   
T cells to produce IL-17, partly in association with IFN-     
(  Fig. 5, B and C  ). 
  IL-17  –  producing cells exclusively originate from a CD161  +   
naive CD4  +   T cell precursor 
  To investigate whether Th17 cells originated from a naive 
CD161  +   precursor, UCB CD4  +   T cells were fi  rst assessed for 
the expression of CD161. As shown in   Fig. 6 A  , fl  ow cyto-
    Figure 4.         Circulating CD4  +  CD161  +   Th17 cells are not NKT, but NKT-like, cells.   (A) The TCR V    24 and TCR V     repertoires were determined by CDR3 
length analysis evaluated by spectratyping. The TCR V    24 and TCR V     repertoires were assessed on freshly isolated (total CD4  + ,  CD4 + CD161 +  , and CD4  + CD161      
T cells) and on 1-wk in vitro  –  expanded CD4  + CD161 +   and  CD4 + CD161       T cells. Representative families of different V     chains assessed (BV3, BV7, BV8, BV9, BV11, 
BV14, BV21, BV22, and BV23) are depicted. One representative out of three different experiments is shown. CDR3 length analysis of V    24 and V    11 in iNKT cells 
is also shown. (B) CD4  + CD161 +   and  CD4 + CD161       T cells were stimulated for 8 h with allogeneic DCs in the presence of an anti  –  MHC class II or an isotype con-
trol mAb, and were then assessed for CD154 expression. Bars represent mean values   ±   SE of percentages of CD154  +   cells obtained in four different experiments. 
(C) A PPD-specifi  c short-term T cell line highly enriched in IL-17  –  producing cells was stimulated for 8 h with PPD-loaded autologous DCs in the presence of an 
anti  –  MHC class II or an isotype control mAb. CD154 and cytokine expression were assessed by fl  ow cytometry. Percentages of gated cells are shown.    JEM VOL. 205, August 4, 2008 
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sence of the polarizing cytokines, the proportion of both Th17 
and Th17/Th1 cells was largely increased (  Fig. 6 D  , right). As 
already observed for total UCB CD4  +   T cells (Fig. S4), neither 
IL-1     nor IL-23 alone, nor any other cytokine or   cytokine 
combination, including IL-6 plus TGF-    , showed the ability 
to induce the appearance of IL-17  –  producing cells in either 
the CD161  +   or the CD161        fraction of UCB CD4  +   T cells 
(unpublished data). 
  Finally, we asked whether the CD161  +   UCB CD4  +   T cells 
that diff  erentiated into Th17 cells were really naive T cells or 
a small subset of contaminating memory T cells. To this end, 
freshly derived UCB CD4  +   T cells were sorted into CD161  +   
was assessed. The addition of IL-1     plus IL-23 resulted in the 
up-regulation of T-bet and ROR    t, as well as the appear-
ance of Th1 cells, in both fractions (  Fig. 6, B and C  ), but the 
development of IL-17  –  producing cells was only observed in 
the CD161  +   fraction (  Fig. 6 C  ). In contrast, the addition of 
IL-12 induced in either CD161  +   or CD161        CD4  +   T cells 
the expression of high levels of T-bet, but not of ROR    t 
(  Fig. 6 B  ), and induced both cell fractions to diff  erentiate into 
Th1 cells (  Fig. 6 C  ). One representative fl  ow cytometric pic-
ture is shown in   Fig. 6 D   (left). When CD161  +   and CD161        
naive CD4  +   T cells were restimulated for an additional 7 d 
with anti-CD3 plus anti-CD28 mAb in the presence or ab-
    Figure 5.         IL-17  –  producing cells can develop from UCB T cells in the presence of IL-1     plus IL-23.   CD4 +   T cells purifi  ed from UCB were stimulated 
for 7 d with anti-CD3 plus anti-CD28 mAb in the presence or absence of the indicated cytokines. (A) ROR    t, T-bet, IL-23R, CD161, and IL-17 mRNA levels were 
measured by real-time quantitative RT-PCR. Bars represent mean values   ±   SE obtained from 13 donors. (B) Cells were also assessed by fl  ow cytometry for their 
ability to produce IFN-     alone (black bars), IL-17 alone (gray bars), or both (white bars) after stimulation with PMA plus ionomycin. Bars represent mean values   ±   SE 
obtained from 13 donors. (C) Representative fl  ow cytometric analysis on UCB CD4  +   T cells after stimulation with anti-CD3 plus anti-CD28 mAb, in the pres-
ence or absence of the indicated cytokines, performed after 1 wk (top) or 2 wk (bottom) of in vitro expansion. p-values refer to the comparison between cul-
tures performed in the presence of the indicated cytokines versus those performed in the presence of medium alone. Percentages of gated cells are shown.    1910 CD161 AND HUMAN T  H  17 CELLS   | Cosmi et al. 
ionomycin, they did not show the ability to produce cytokines 
(except IL-2;   Fig. 7 A  , right).   Moreover, TCR excision circle 
(TREC) levels were examined in the two sorted popula-
tions and compared with those found in purifi  ed CD45RA      
CD45RO  +   adult circulating CD4  +   T cells. As shown in   Fig. 
7 B  , TREC levels were quite comparable in CD161  +   and 
and CD161        cells, and the expression of some phenotypic 
markers, as well as the ability to produce cytokines after stim-
ulation with PMA plus ionomycin, were examined. Virtually 
all purifi  ed CD161  +  CD4  +  , as well as CD161       , UCB T cells 
expressed CD45RA (even if often in association with CD45RO) 
and CD31 (  Fig. 7 A  , left), and when stimulated with PMA plus 
    Figure 6.         UCB CD161  +  CD4  +   T cells constitutively express ROR    t, IL-23R, and CCR6 mRNA and differentiate into Th17 cells in response to IL-
1     plus IL-23.   (A) Flow cytometric detection of CD161  +   cells among UCB CD4  +   T cells and measurement of ROR    t, IL-23R, CCR6, and IL-17 mRNA levels in 
CD161-depleted (black bars) and CD161-enriched (red bars) unstimulated UCB CD4  +   T cells. Bars represent mean values   ±   SE obtained in seven different 
donors. (B) CD4  + CD161 +   (red bars) and CD4  + CD161       (black bars) T cells were stimulated for 7 d with anti-CD3 plus anti-CD28 mAb in the presence or absence 
of the indicated cytokines. ROR    t and T-bet mRNA levels were measured by real-time quantitative RT-PCR. Bars represent mean values   ±   SE obtained from 
six donors. (C) The same cell fractions as in B were assessed by fl  ow cytometry for their ability to produce IFN-     and IL-17 after stimulation with PMA plus 
ionomycin. Bars represent mean values   ±   SE obtained from six donors. (D) Representative fl  ow cytometric analysis of cytokine production by CD4  + CD161 +  
(red plots) and CD4  + CD161       (black plots) T cells after 1 wk (left) or 2 wk (right) of in vitro expansion. p-values refer to the comparison between cultures per-
formed in the presence of the indicated cytokines versus those performed in the presence of medium alone. Percentages of gated cells are shown.    JEM VOL. 205, August 4, 2008 
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to diff  erentiate into IL-17  –  producing cells after polyclonal 
activation in the presence of IL-1     and IL-23, whereas CD4  + 
CD161        thymocytes could not (  Fig. 8 B  ).   
    DISCUSSION   
  This study demonstrates that, at least in humans, IL-17  –  pro-
ducing CD4  +   T cells consistently express CD161 as an un-
expected surface marker and originate from an NKT-like 
CD4  +   T cell precursor. These observations originated from the 
results of a microarray analysis performed on human CD4  +   
T cell clones. This analysis showed that, in addition to up-
regulated genes coding for molecules already known to be 
expressed by human Th17 cells, such as   IL-17  ,   IL-26  ,   IL-
23R  ,   ROR    t  , and   CCR6   (  7, 8, 13  ), the   CD161   gene was 
also highly up-regulated on Th17 compared with either Th1 
or Th2 clones. More importantly, all IL-17  –  producing cells 
were contained within the CD161  +   fraction of adult circulat-
ing CD4  +   T cells. Of note, virtually all CD161  +   cells were 
contained in the CD45RA       CD45RO  +  CD31        population, 
suggesting their nature as memory T cells. Moreover, among 
these cells there was a strict association between the expression 
CD161        UCB CD4  +   T cells and signifi  cantly higher than 
in purifi  ed CD45RA       CD45RO  +   adult circulating CD4  +   T 
cells. To provide additional evidence that UCB CD161  +   T 
cells that gave origin to Th17 cells were not contaminating 
memory T cells, the CD161  +   fraction of UCB CD4  +   T cells was 
depleted of all CD45RO  +   cells (including the double-positive 
CD45RA  +  CD45RO  +   cells), and the remaining population, 
consisting only of CD45RA  +  CD45RO        cells, was stimulated 
with anti-CD3 plus anti-CD28 mAb in the presence of IL-1     
plus IL-23. As shown in   Fig. 7 C  , despite the depletion of all 
cells expressing CD45RO, the remaining CD45RA  +  CD161  +   
UCB T cells maintained the ability to diff  erentiate into IL-17  –
  producing cells. 
  To defi  nitively demonstrate the existence of a CD4  +  CD161  +   
precursor of human Th17 cells, experiments using T cells 
from postnatal human thymuses were also performed. A few 
(0.65   ±   0.15% SE) single-positive CD4  +  CD8        thymocytes 
were found to express CD161 and could be separated from 
CD161        CD4  +  CD8        thymocytes. As shown in   Fig. 8  , only 
purifi  ed CD4  +  CD161  +   thymocytes constitutively expressed both 
ROR    t and IL-23R mRNA (  Fig. 8 A  ) and could be induced 
    Figure 7.         UCB CD161  +  CD4  +   T cells that differentiate into Th17 are naive T cells.   (A) Representative fl  ow cytometric analysis of CD45RA, 
CD45RO, and CD31 (left) and cytokine production after stimulation with PMA plus ionomycin (right) by freshly isolated CD161  +   (red plots) and CD161       
(black plots) UCB CD4  +   T cells. Percentages of gated cells are shown. (B) TREC analysis was performed by quantitative PCR on freshly isolated 
CD4  + CD161 +   (red bar) or CD4  + CD161       (black bar) UCB CD4  +   T cells and on circulating CD45RA      CD45RO +   CD4 +   T cells from adult donors (white bar). 
Bars represent mean values   ±   SE obtained in three different UCB or PB adult donors. (C) UCB CD4  +   T cells were depleted of CD45RO  +   cells  (including 
double-positive CD45RA  + CD45RO +   cells) by FACS using an anti-CD45RO  –  APC mAb. The fraction containing only CD45RA  + CD45RO       (gray bars) and the 
fraction containing the remaining CD45RO  +   cells (white bars) were activated with anti-CD3/CD28 mAb in the absence (medium) or presence of IL-1    
plus IL-23. Bars represent mean values   ±   SE obtained in three different UCB donors.     1912 CD161 AND HUMAN T  H  17 CELLS   | Cosmi et al. 
NK cells but also by a subset of T cells that have been named 
NKT cells (  24, 25  ). The classical, type I NKT cells are     -ga-
lactosylceramide reactive and CD1d restricted, and use an in-
variant TCR      chain consisting of V    14-J    18 and a limited 
     chain repertoire dominated by V     8.2, V    7, or V    2 in 
mice, and of V    24-J    18 with V    11 in humans (  24, 25  ). The 
iNKT cells, at least in mice, may be CD4  +   or double-negative 
and are able to produce large amounts of diff  erent cytokines 
after stimulation (  24, 25  ). In addition to iNKT, NKT cells not 
bearing the V    24-J    18 (human) or the V    14-J    18 (mice) 
TCR, but still dependent on CD1d antigen presentation, have 
also been identifi  ed and named as nonclassical or type II NKT 
cells (  20  ). These cells can express diverse but few (V    3.2-J    9 
and V    8) TCR      chains and can be identifi  ed by CD1d tet-
ramers (  26, 27  ). However, other cell types that express CD161 
but are restricted by conventional MHC molecules instead of 
CD1d and, therefore, exhibit noninvariant TCRs, have been 
described in humans and named as NKT-like CD4  +   or CD8  +   
T cells (  20, 28  ). CD161  +   cells were found to be a minority 
(about one out of fi  ve) among human circulating CD4  +   T 
cells (  29  ), with the great majority of them expressing CD45RO, 
which suggests their nature as memory T cells (  24, 30  ). In con-
trast, the percentage of iNKT cells among human circulating 
CD4  +   T cells is   <  1% (  29  ), which is in contrast with the obser-
vations in mice, where the majority of circulating NK1.1  +   cells 
are iNKT cells (  24  –  32  ). The IL-17  –  producing CD161  +  CD4  +   
T cells described in this study were not CD1d-restricted NKT 
cells because they had a TCR V     and V     repertoire hetero-
geneity incompatible with CD1d restriction, and their re-
sponse to allogeneic stimulation or stimulation with a soluble 
antigen, such as PPD, was inhibited by blocking MHC class II. 
Despite the fact that human IL-17  –  producing cells are not 
iNKT but NKT-like cells, our fi  ndings may appear in dis-
agreement with those reported in mice showing that a subset 
of iNKT cells produces IL-17, but curiously, whereas most 
mouse iNKT cells express NK1.1 (NKR-P1C), the IL-17  –
  producing iNKT cells are NK1.1        (  33, 34  ). However, by us-
ing the microarray assay on mouse NKT cells, production of 
IL-17 by both NK1.1  +   and NK1.1        cells upon activation 
in vitro has also been reported (  35  ). 
  The most intriguing observation emerging from this 
study was the demonstration that not only do human Th17 
cells express CD161 during their life, but they can also exclu-
sively originate from a CD161  +   naive CD4  +   T cell precur-
sor. In agreement with the results previously reported by van 
Beelen et al. (  17  ), we were unable to induce the development 
of Th17 cells from the purifi  ed CD45RA  +  CD45RO        (naive) 
circulating CD4  +   T cells of adult subjects. Accordingly, virtu-
ally no CD161  +   cells were found by us within the CD45RA  + 
CD45RO        population of adult circulating CD4  +   T cells. 
In contrast, in this study small numbers of Th17 cells origi-
nated from human UCB CD4  +   T cells after polyclonal stimula-
tion with anti-CD3/CD28 mAb in the presence of IL-1     
plus IL-23. Notably, when UCB CD4  +   T cells were sorted 
into CD161        and CD161  +   cells, constitutive expression of 
ROR    t, IL-23R, and CCR6 was found, but only in the 
of CD161 and CCR6, a chemokine receptor which has been 
found to be prevalently expressed by human Th17 cells (  7, 8  ), 
such that virtually all IL-17  –  producing cells appeared to be 
contained in the CCR6  +   fraction of the CD161  +   population. 
Accordingly, IL-23R and ROR    t mRNA expression was 
restricted to the CD161  +  CCR6  +   cell fraction. The ability to 
produce IL-22 after stimulation was virtually restricted to the 
CD161  +   circulating CD4  +   T cells, whereas the production of 
IL-21 was shared by both CD161  +   and CD161        circulating 
CD4  +   T cells. The latter fi  ndings are in keeping with previous 
observations showing that IL-21 production is not restricted 
to Th17 cells (  21  ), whereas IL-22 and IL-17 are coexpressed 
by Th17 cells (  22  ). 
  CD161 (or NKR-P1A) is the human homologue of the 
mouse NK1.1 (  23  ), which is expressed not only on almost all 
    Figure 8.         CD161  +   but not CD161            thymocytes constitutively ex-
press ROR    t and IL-23R and can be induced to differentiate to Th17 
cells.   (A) ROR    t and IL-23R mRNA levels detected in CD161        (black  bars) 
and CD161  +   (red bars) cells sorted from single-positive CD4  + CD8       human 
thymocyte suspensions. Bars represent mean values + SE obtained in three 
different donors. (B) Representative fl  ow cytometric analysis of IL-17 and 
IFN-     production by CD4  + CD161 +   (red plots) and CD4  + CD161       (black  plots) 
thymocytes after 1 wk of in vitro expansion with anti-CD3/CD28 mAb in 
the absence (medium) or presence of IL-1     plus IL-23. Comparable results 
were obtained with CD161        and  CD161 +   thymocytes from the other two 
postnatal human thymuses. Percentages of gated cells are shown.     JEM VOL. 205, August 4, 2008 
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presence of IL-1     plus IL-23, with the presence of IL-12 be-
ing determinant for the Th1 choice. Therefore, the origin of 
human Th17 cells seems to be more similar to that initially 
reported in mice, when it was thought to depend on the bal-
ance between IL-12 and IL-23 production and their interac-
tion with IL-12R or IL-23R, respectively (  36  ). 
  The mechanisms linking together the expression of CD161 
and the ability to develop into IL-17  –  producing cells in the 
presence of the appropriate cytokines (IL-1     plus IL-23) are 
still unclear. Cross-linking of CD161 by a plate-bound anti-
CD161 mAb did not exert any eff  ect on the proliferation or 
cytokine production by CD161  +   cells (unpublished data), 
thus excluding that CD161 ligation may play some role in 
the expansion or eff  ector functions of these cells. Another 
more likely explanation is that CD161, present on CD4  +   T 
cells as well as on TCR          +   cells, is implicated in their trans-
endothelial migration (  37, 38  ). Although CD161 is expressed 
on a minority of human circulating CD4  +   T cells (  30  ), an 
abundance of CD161  +   cells represented the majority of T 
cells from the epithelial and lamina propria layers of the hu-
man colon (  39  ). Recently, it was found that high numbers of 
Th17 cells are constitutively present in diff  erent compart-
ments of the mouse gut, and their numbers correlate with the 
bacterial load of the gut segments (thus being preeminent in 
the lamina propria of the colon), whereas low numbers were 
found in the spleen and liver (  40  ). One physiological ligand for 
human CD161 has been identifi  ed as the lectin-like transcript 1, 
which belongs to the C-type lectin domain family 2 (CLEC2) 
(  41  ). Another member of the CLEC2 family, CLEC2A, has 
been found to be selectively expressed in the skin (  42  ), where 
Th17 cells migrate in the course of chronic infl  ammatory dis-
orders, such as contact dermatitis, psoriasis, and atopic derma-
titis (  19  ). The results of our study show that several CD161  +   
cells are present among T cells infi  ltrating the skin of psoriatic 
patients and that virtually all CD4  +   T cells able to produce 
IL-17 in the gut of subjects with CD, or in the skin of those 
suff  ering from psoriasis, were contained within the cell popu-
lation expressing CD161. This fi  nding supports the possibility 
that this molecule plays an important role in favoring trans-
endothelial migration of Th17 eff  ectors into tissues, where 
they are recruited in response to the CCR6-binding chemo-
kine CCL20 (  7, 8  ). However, it cannot be excluded, as sug-
gested previously in this paragraph, that this molecule is also 
critical for the transendothelial migration of Th17 precursors 
early in life. In conclusion, we have identifi  ed CD161 as one 
of the most important surface markers of human IL-17  –  pro-
ducing cells, and we have demonstrated that, at least in hu-
mans, IL-17  –  producing cells can only originate from a naive 
CD161  +  CD4  +   T cell precursor. 
  MATERIALS AND METHODS 
  Subjects.     UCB samples were obtained from 23 donors. Small bowel speci-
mens were obtained from disease-aff  ected gut areas of three subjects with 
CD, and skin biopsy specimens were obtained from the lesional skin of three 
patients aff  ected by psoriasis. Normal skin, taken from the abdominal skin of 
three healthy volunteers who underwent minor surgery (in whom no cuta-
neous or systemic infl  ammatory diseases were diagnosed), served as a control. 
CD161  +   fraction. More importantly, Th17 cells only de-
veloped from the CD161  +   fraction and their frequency could 
reach substantial levels (  >  20%) after a repeated 2-wk stim-
ulation. Because UCB CD4  +   T cells consisted not only 
of CD45RA  +  CD45RO        cells but also of double-positive 
CD45RA  +  CD45RO  +   cells, whose functional nature is dif-
fi  cult to defi  ne, the possibility that UCB CD161  +   cells 
give rise to IL-17  –  producing cells, representing the expan-
sion of a small population of contaminating memory T cells 
present in the UCB as a consequence of fetal immune sys-
tem stimulation during pregnancy, could be hypothesized. 
However, this possibility can be reasonably excluded on 
the basis of three main observations. First, neither CD161  +   
nor CD161        UCB CD4  +   T cells produced any cytokine in 
response to stimulation with PMA plus ionomycin except 
IL-2, which is a functional property of naive T cells. Sec-
ond, both CD161  +   and CD161        cells showed comparable 
TREC levels, which were signifi  cantly higher than those 
of CD4  +  CD45RA       CD45RO  +   (memory) adult circulating 
T cells. Third, when the CD161  +   fraction of UCB CD4  +   T 
cells was completely deprived of CD45RO  +   cells, includ-
ing those coexpressing CD45RA, the remaining CD45RA  + 
CD45RO        population maintained the ability to diff  erenti-
ate into IL-17  –  producing cells in response to the stimulation 
with anti-CD3/CD28 mAb in the presence of IL-1     plus 
IL-23. Finally, and more importantly, completely similar re-
sults were obtained when the small population of CD161  +   
cells present among single-positive CD4  +  CD8        T cells of post-
natal human thymuses was assessed. Obviously, why CD161  +   
UCB or thymic naive T cells can diff  erentiate into Th17 cells, 
whereas purifi  ed CD45RA  +  RO        circulating CD4  +   T cells 
from adult subjects do not (see Results) (  17  ), remains unclear. 
However, the latter fi  nding is in keeping with the observation 
reported in this paper that CD161  +   cells are apparently not 
present in the CD45RA  +  CD45RO        fraction of circulating 
CD4  +   T cells from adult subjects. Thus, if adult circulating 
CD45RA  +  CD45RO        cells contain some Th17 precursors, 
they are certainly present in much lower proportions than in 
UCB. One might speculate that Th17 responses are mainly 
mounted during the perinatal period. However, this would 
imply that for an eff  ective Th17 response, all possible bacte-
rial pathogens should present themselves during the perinatal 
period, which is very unlikely. Thus, a more likely possibility 
to explain why Th17 precursors are more numerous in UCB 
than in adult blood may be that they migrate very early into 
tissues, where they can diff  erentiate into IL-17  –  producing 
cells even later in life. 
  The results of this study also support our previous fi  nd-
ings suggesting that human Th1 and Th17 cells may have a 
close developmental relationship (  8  ). We could indeed con-
fi  rm that a substantial proportion of IL-17  –  producing cells, 
even after their development from naive CD4  +   T cells, also 
possess the ability to produce IFN-     (Th17/Th1), which may 
represent an intermediate phenotype between Th1 and Th17 
cells. Moreover, we clearly showed that human naive CD4  +   
T cells can give origin to either Th1 or Th17 cells in the 1914 CD161 AND HUMAN T  H  17 CELLS   | Cosmi et al. 
as feeder cells, 1% PHA (vol/vol), and 50 U/ml rIL-2. Growing microcul-
tures were then supplemented at weekly intervals with 50 U/ml IL-2 and 10  5   
irradiated allogeneic PBMCs as feeder cells. Recovered CD4  +   T cell clones 
were classifi  ed into Th1, Th2, or Th17 subsets on the basis of their ability to 
produce IFN-    , IL-4, or IL-17, respectively, as assessed by single-cell fl  ow 
cytometry after polyclonal stimulation. 
  iNKT cell culture.     PBMCs were expanded in the presence of 100 U/ml rIL-2 
and 100 ng/ml     -galactosylceramide (ALEXIS Biochemicals) for 2 wk. The 
cells were then sorted using anti-V    11 and -V    24 mAbs (Beckman Coulter). 
  Intracellular cytokine and CD154 detection assay.     Intracellular stain-
ing for IFN-    , IL-17, IL-4, and IL-2 was performed as previously described 
(  8  ). 10  5   CD4  +  CD161  +   and CD4  +  CD161        cells were cultured with or with-
out 0.5   ×   10  5   irradiated (9,000 rad) allogeneic DCs in the presence of 5   μ  g/ml 
anti  –  MHC class II (clone Tu39, mouse IgG2a) mAb or 5   μ  g/ml of isotype 
control mAbs for 8 h, with the last 6 h in the presence of brefeldin A. 
CD154 detection was performed according to a previously described tech-
nique (  43  ). In one experiment, a PPD-specifi  c short-term T cell line, ob-
tained as described previously (  44  ), was stimulated for 8 h (the last 6 h in the 
presence of brefeldin A) with PPD-loaded autologous DCs in the presence 
of an anti  –  MHC class II or an isotype control mAb. Cells were stained for 
CD3, CD4, CD154, intracellular IFN-    , and IL-17, and analyzed by fl  ow 
cytometry. PPD was obtained from Novartis. 
  Confocal microscopy.     Detection of CD161 on T cells present in biopsy 
specimens of normal skin or in lesional skin from psoriatic patients was per-
formed by confocal microscopy on 5-  μ  m sections of frozen skin tissues by 
using a laser confocal microscope (LSM 510META; Carl Zeiss, Inc.), as pre-
viously described (  8  ). For this staining, unlabeled anti-CD3 mAb (clone 
UCHT1) was obtained from BD Biosciences, and unlabeled anti-CD161 
mAb was obtained from Miltenyi Biotec. 
  RNA isolation, cDNA synthesis, and real-time quantitative RT-PCR.   
  Total RNA was extracted by using the RNeasy Micro Kit (QIAGEN) and 
treated with DNase I to eliminate possible genomic DNA contamination. 
TaqMan RT-PCR was performed, as previously described (  8  ). Primers and 
probes used were purchased from Applied Biosystems. 
  Microarray.     Gene expression profi   les on human Th1, Th2, and Th17 
clones were assessed by cDNA microarray technique using the Human Ge-
nome Survey Microarray (Applied Biosystems). In brief, RNA from diff  er-
ent samples was amplifi  ed and labeled with Digoxigenin-UTP (DIG-UTP; 
Applied Biosystems). 10   μ  g of DIG-labeled cRNA was hybridized to the 
Human Genome Survey Microarray and read using the 1700 Chemilumi-
nescent Microarray Analyzer (Applied Biosystems). Expression Array System 
software (Applied Biosystems) was used to analyze the microarrays images. 
Only microarrays showing a normalized signal intensity   >  5,000 and a me-
dian background   <  600 were analyzed and normalized using Spotfi  re and 
Intergomics software (Spotfi  re Inc.). Class comparisons expressed as Ben-
jamini-Hochberg false discovery rates were done using parametric tests 
(LIMMA) after log transformation. Each sample was analyzed three times. 
Microarray data are available from the Gene Expression Omnibus database 
under accession no.   GSE11553  . 
  TCR analysis.     The TCR repertoire was studied by CDR3 length analysis, 
a well-established PCR-based technique we refer to as spectratyping or 
immunoscope (  45, 46  ). cDNAs recovered from the diff  erent samples and 
culture conditions described were amplifi  ed under nonsaturating PCR con-
ditions with   TCR-BV   or   TCR-AV   family-specifi  c primers (  45, 46  ). Each 
reaction contained a     -actin  –  specifi  c primer pair producing a 6-FAM  – 
labeled 230-bp product as an internal control (  47  ). The amount of template 
cDNA for each sample was assessed by preliminary titration amplifying 
for total TCR message (  46, 47  ). Each diff  erent PCR product was run in a 
fl  uorescence-based DNA sequencer (ABI 377; Applied Biosystems) with 
Peripheral blood (PB) samples were obtained from seven healthy volunteers. 
Three postnatal thymuses were obtained from children (aged between 3 and 
15 d) subjected to cardiac surgery. The procedures and all of the experiments 
of the study were in accordance with the ethical standards of and approved 
by the Regional Committee on Human Experimentation. 
  Reagents.     RPMI 1640 medium (Seromed) was used, supplemented with 
2 mM   l-  glutamine, 1% nonessential amino acids, 1% sodium pyruvate, and 
2   ×   10      5   M 2-ME (all from Invitrogen), and 10% FCS (HyClone; Invitrogen). 
Unlabeled or fl  uorochrome-conjugated anti-CD3, -CD4, -CD8, -CD14, 
-CD16, -CD19, -CD28, -CD31, -CD34, -CD45RA, -CD45RO, -CD56, 
-CD154, -CD161, -CCR6,   –  glycophorin A/B, -TCR        ,   –  MHC class II 
(clone Tu39, mouse IgG2a; BD Biosciences),   –  IFN-    ,   –  IL-2,   –  IL-4, and 
isotype-matched control mAbs were purchased from BD Biosciences. The 
fl  uorochrome-conjugated anti  –  IL-17,   –  IL-21 and   –  IL-22 mAbs were ob-
tained from eBioscience. PMA, ionomycin, and brefeldin A were purchased 
from Sigma-Aldrich. The cytokines IL-1    , IL-6, IL-12, IL-23, and TGF-     
were purchased from R  &  D Systems. IL-21 was purchased from Invitrogen. 
  CD4  +   T cell recovery and expansion.     MNC suspensions were obtained 
from UCB and PB by centrifugation on Ficoll-Hypaque gradient. Isolation 
of CD4  +   T cells from UCB or PBMCs was performed by using the CD4 
isolation kit II (Miltenyi Biotec). For isolation of human single-positive 
CD4  +  CD8        thymocytes, thymic tissue fragments were mechanically dis-
rupted with a MEDI machine (BD Biosciences). MNCs were separated from 
the other cells by Ficoll-Hypaque gradient centrifugation. Thymic MNC 
suspensions were incubated for 20 min with anti-CD8, -CD14, -CD16, 
-CD19, -CD34, -CD56, -TCR        , and   –  glycophorin A/B mAbs and exten-
sively washed, and then incubated for an additional 20 min with goat anti  –
  mouse microbead-conjugated polyclonal antibody (Miltenyi Biotec). After 
washing, cells were separated on a CS+ column. Purifi  ed UCB-, PB- and 
thymus-derived CD4  +   cells were further divided into CD161  +   and CD161        
cells by an anti-CD161  –  PE or   –  allophycocyanin (APC) mAb, followed by 
an anti-PE or -APC microbead mAb (Miltenyi Biotec). Purifi  ed UCB, PB, 
and thymus-derived CD4  +  CD161  +   and CD4  +  CD161        T cells were (a) ana-
lyzed by fl  ow cytometry for surface marker expression, (b) stimulated for 
  intracellular cytokine detection, (c) analyzed by quantitative PCR for gene 
expression, and (d) stimulated for 7 d with 5   μ  g/ml anti-CD3 plus 5   μ  g/ml 
anti-CD28 mAbs in the absence or presence of 10 ng/ml IL-1    , 2 ng/ml 
IL-6, 2 ng/ml IL-12, 20 ng/ml IL-23, 5 ng/ml TGF-    , or 50 ng/ml IL-21, 
or combinations of them. On day 7, T cells were analyzed by quantitative 
PCR for gene expression and stimulated for intracellular cytokine detection. 
UCB CD4  +  CD161  +   and CD4  +  CD161        T cell lines were restimulated under 
the same conditions described for an additional 7 d and were then analyzed 
by fl  ow cytometry for intracellular cytokine production. In an additional ex-
periment, PB CD4  +  CD161  +   and CD4  +  CD161        T cell populations were 
further divided in CCR6  +   and CCR6        cell fractions by a FACSAria (BD 
Biosciences); each purifi  ed T cell population was analyzed by quantitative 
PCR for IL-23R and ROR    t mRNA expression and by fl  ow cytometry 
for intracellular cytokine production after PMA plus ionomycin stimulation. 
In additional experiments, PB CD4  +   and UCB CD4  +  CD161  +   T cell popu-
lations were further purifi  ed in the CD45RA  +  CD45RO        cell fraction by 
using CD45RO microbead (MACS; Miltenyi Biotec) or CD45RO-APC 
(FACSAria) mAbs. For isolation of T lymphocytes from the gut and skin bi-
opsies, tissues fragments were mechanically disrupted with a MEDI machine. 
Cell suspensions were stimulated for 7 d with anti-CD3 plus anti-CD28 mAbs 
in the presence of 20 IU/ml IL-2. On day 7, T cells were analyzed by fl  ow 
cytometry for intracellular cytokine production. CD4  +  CD45RA       CD45RO  +   
memory T cells used for TREC analysis were obtained by using the CD4 
isolation kit II, and CD45RA depletion was performed by using an anti-
CD45RA microbead mAb (Miltenyi Biotec). T cell clones were generated 
from the PBMCs of adult healthy donors and categorized into Th1, Th2, and 
Th17 subsets, as reported previously (  8  ). In brief, CD4  +   cells were seeded 
under limiting-dilution conditions (0.5 cells per well) in round-bottom mi-
crowell plates (Nunc) containing 10  5   irradiated (6,000 rad) allogeneic PBMCs JEM VOL. 205, August 4, 2008 
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Rox-labeled size markers (Applied Biosystems), as previously described (  46, 
47  ). The data were analyzed using Genescan software (Applied Biosystems) 
to assign size and peak areas to the diff  erent PCR products. 
  TREC analysis.     TRECs were assessed using a procedure that was previ-
ously described (  48, 49  ). DNA was extracted by the diff  erent cell popula-
tions using a RepliQ-mini kit (QIAGEN). The PCR amplifi  cation was 
performed using an ABI 7500 (Applied Biosystems), and primer cycling and 
conditions have been previously reported (  48, 49  ). As a standard to calculate 
the number of copies, we used a cloned Sj TREC fragment inserted in the 
Hind III site of a pUC-19 vector. The number of Sj copies present in a given 
cell population was calculated by diluting this standard in each PCR experi-
ment. As a control for memory T cells, we used DNA of CD4  +  CD45RA-
CD45RO  +   T cells sorted from the PBMCs of a normal donor. 
  Statistics.     A standard two-tailed paired   t   test was used for statistical analysis. 
P   ≤   0.05 was considered signifi  cant. 
  Online supplemental material.     Fig. S1 shows that CD161 expression by 
Th17 clones is not aff  ected by in vitro polyclonal activation. Fig. S2 pro-
vides an analysis of CD45RA, CD45RO, and CD31 in sorted CD161  +   and 
CD161        circulating CD4  +   T cells from adult subjects. Fig. S3 shows the pro-
duction of IL-21 and IL-22 by CD161        and CD161  +   cell fractions from circu-
lating CD4  +   T cells of adult subjects. Fig. S4 shows the expression of mRNA 
for ROR    t, IL-23R, IL-17, and CD161 by UCB CD4  +   T cells stimulated in 
the presence of diff  erent cytokines or cytokine combinations. Fig. S5 shows 
the CD161  +   expression by sorted CD161  +   and CD161        cell fractions. Tables 
S1  –  S4 show microarray data of T cell clones. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20080397/DC1. 
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